首页 > 最新文献

Revue d''Homeopathie最新文献

英文 中文
Quelques informations 一些资料
Q4 Medicine Pub Date : 2021-12-01 DOI: 10.1016/j.revhom.2021.10.022
{"title":"Quelques informations","authors":"","doi":"10.1016/j.revhom.2021.10.022","DOIUrl":"https://doi.org/10.1016/j.revhom.2021.10.022","url":null,"abstract":"","PeriodicalId":39101,"journal":{"name":"Revue d''Homeopathie","volume":"12 4","pages":"Pages 264-265"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136591697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Q4 Medicine Pub Date : 2021-12-01 DOI: 10.1016/j.revhom.2021.10.019
Alain Sarembaud (Médecin homéopathe)
{"title":"","authors":"Alain Sarembaud (Médecin homéopathe)","doi":"10.1016/j.revhom.2021.10.019","DOIUrl":"10.1016/j.revhom.2021.10.019","url":null,"abstract":"","PeriodicalId":39101,"journal":{"name":"Revue d''Homeopathie","volume":"12 4","pages":"Page 267"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123721326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
À propos d’un délire de type schizophrénique. Approche homéopathique 关于精神分裂症型谵妄。顺势疗法的方法
Q4 Medicine Pub Date : 2021-12-01 DOI: 10.1016/j.revhom.2021.10.004
Dr. Daniel Wiedemann (Médecin homéopathe)

Through a clinical case of schizophrenia, we will specify the type of hallucinations corresponding to Alumina, thus enabling us to propose 4 index additions to the “Hallucinations ” sections of the homeopathic repertories. Alumina has been the main and the most effective homeopathic medicine prescribed, in combination with neuroleptics. The beneficial collaboration of the psychiatrist and the homeopathic doctor led to the complete cure of a young schizophrenic man with a follow-up of more than 20 years.

通过一个精神分裂症的临床病例,我们将具体说明与氧化铝相对应的幻觉类型,从而使我们能够在顺势疗法剧目的“幻觉”部分提出4个索引添加。氧化铝一直是主要和最有效的顺势疗法药物,与抗精神病药联合使用。精神科医生和顺势疗法医生的有益合作导致了一个年轻的精神分裂症患者在20多年的随访中完全治愈。
{"title":"À propos d’un délire de type schizophrénique. Approche homéopathique","authors":"Dr. Daniel Wiedemann (Médecin homéopathe)","doi":"10.1016/j.revhom.2021.10.004","DOIUrl":"10.1016/j.revhom.2021.10.004","url":null,"abstract":"<div><p>Through a clinical case of schizophrenia, we will specify the type of hallucinations corresponding to <em>Alumina</em>, thus enabling us to propose 4 index additions to the “Hallucinations ” sections of the homeopathic repertories. Alumina has been the main and the most effective homeopathic medicine prescribed, in combination with neuroleptics. The beneficial collaboration of the psychiatrist and the homeopathic doctor led to the complete cure of a young schizophrenic man with a follow-up of more than 20 years.</p></div>","PeriodicalId":39101,"journal":{"name":"Revue d''Homeopathie","volume":"12 4","pages":"Pages 228-230"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115696654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mémoire de l’eau : une expérience vécue 水的记忆:一种生活体验
Q4 Medicine Pub Date : 2021-12-01 DOI: 10.1016/j.revhom.2021.10.025
Bernard Poitevin (Allergologue, MG à orientation homéopathie)

La controverse à propos de la “mémoire de l’eau” ne peut se comprendre que si le volet médiatique de cette “affaire” est dissocié des publications scientifiques sur ce sujet et des sources médicales homéopathiques qui en ont été à l’origine. Si l’aspect médiatique a été excessivement développé, la répétabilité des travaux scientifiques s’est avérée insuffisante, les efforts faits par la communauté homéopathique ayant été limités. Ceci a eu des conséquences sur l’évolution de la recherche en homéopathie et indirectement sur l’arrêt du remboursement de l’homéopathie par la Sécurité sociale en France.

The controversy surrounding “water memory” can only be understood if the media component of this “affair” is separated from the scientific publications on this subject and the original homeopathic medical sources. While the media aspect was out of proportion, the reproducibility of the scientific work proved to be insufficient, the efforts made by the homeopathic community having been limited. This had consequences on the evolution of research in homeopathy and indirectly on the decision to stop the reimbursement of homeopathy by the French social security system.

关于“水的记忆”的争议只有在媒体对这一“事件”的报道与有关这一主题的科学出版物和顺势疗法医学来源分离的情况下才能理解。虽然媒体方面被过度发展,但科学工作的可重复性被证明是不够的,顺势疗法社区的努力是有限的。这对顺势疗法研究的发展产生了影响,并间接地影响了法国社会保障机构对顺势疗法的补偿的终止。只有将这一“事件”的媒体组成部分与有关这一主题的科学出版物和原始顺势疗法医学来源分开,才能理解围绕“水记忆”的争议。虽然媒体方面不成比例,但科学工作的重现性证明是不够的,顺势疗法社区所做的努力是有限的。这对顺势疗法研究的发展产生了影响,并对停止法国社会保障体系对顺势疗法的补偿的决定产生了直接影响。
{"title":"Mémoire de l’eau : une expérience vécue","authors":"Bernard Poitevin (Allergologue, MG à orientation homéopathie)","doi":"10.1016/j.revhom.2021.10.025","DOIUrl":"10.1016/j.revhom.2021.10.025","url":null,"abstract":"<div><p>La controverse à propos de la “mémoire de l’eau” ne peut se comprendre que si le volet médiatique de cette “affaire” est dissocié des publications scientifiques sur ce sujet et des sources médicales homéopathiques qui en ont été à l’origine. Si l’aspect médiatique a été excessivement développé, la répétabilité des travaux scientifiques s’est avérée insuffisante, les efforts faits par la communauté homéopathique ayant été limités. Ceci a eu des conséquences sur l’évolution de la recherche en homéopathie et indirectement sur l’arrêt du remboursement de l’homéopathie par la Sécurité sociale en France.</p></div><div><p>The controversy surrounding “water memory” can only be understood if the media component of this “affair” is separated from the scientific publications on this subject and the original homeopathic medical sources. While the media aspect was out of proportion, the reproducibility of the scientific work proved to be insufficient, the efforts made by the homeopathic community having been limited. This had consequences on the evolution of research in homeopathy and indirectly on the decision to stop the reimbursement of homeopathy by the French social security system.</p></div>","PeriodicalId":39101,"journal":{"name":"Revue d''Homeopathie","volume":"12 4","pages":"Pages 242-253"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128567762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systematisation of homeopathic consultations and collection of medicinal effects applied to a population of agents of the Régie Autonome des Transports Parisiens (RATP) 顺势疗法咨询的系统化和对巴黎交通管理局(RATP)代理人群的疗效收集
Q4 Medicine Pub Date : 2021-12-01 DOI: 10.1016/j.revhom.2021.10.018
Jean-Paul Billot (Médecin gériatre homéopathe)

This study concerns a series of 1022 patients from the Paris metro treated by homeopathy over several decades. It attempts to define the extent to which observational studies can be used to evaluate the medical-social impact, the theoretical validity and the effects of homeopathic therapy, an original discipline, straddling the empirical and the experimental, a meeting point between the labelled illness and the illness as it is experienced by the patient. To do this, all the information noted about each patient and all the effects occurring after each prescription must be systematically collected and classified. This then needs to be integrated into a databank and must be made available to researchers. The aim here is to determine the position of homeopathy in medicine and analyse the benefit and limits of observational studies. The method used within the RATP medical service will then be defined. Next, the patients are classified according to their geographical origin, gender, age, their consultations over time and their role in the company. Finally, the consultations are quantified: number, sex ratio, by year, by patient and by motive and type of pathology according to the CIST 2 classification.

这项研究涉及几十年来在巴黎地铁接受顺势疗法治疗的1022名患者。它试图定义观察性研究可用于评估顺势疗法的医学-社会影响、理论有效性和效果的程度,顺势疗法是一门跨越经验和实验的原创学科,是标签疾病和患者所经历的疾病之间的交汇点。要做到这一点,必须系统地收集和分类每个病人的所有信息和每个处方后发生的所有效果。然后,这需要整合到一个数据库中,并且必须提供给研究人员。本文的目的是确定顺势疗法在医学中的地位,并分析观察性研究的益处和局限性。然后将定义RATP医疗服务中使用的方法。接下来,根据患者的地理来源,性别,年龄,他们的咨询时间和他们在公司的角色进行分类。最后,咨询是量化的:数量,性别比例,按年,按病人,动机和病理类型根据CIST 2分类。
{"title":"Systematisation of homeopathic consultations and collection of medicinal effects applied to a population of agents of the Régie Autonome des Transports Parisiens (RATP)","authors":"Jean-Paul Billot (Médecin gériatre homéopathe)","doi":"10.1016/j.revhom.2021.10.018","DOIUrl":"10.1016/j.revhom.2021.10.018","url":null,"abstract":"<div><p>This study concerns a series of 1022 patients from the Paris metro treated by homeopathy over several decades. It attempts to define the extent to which observational studies can be used to evaluate the medical-social impact, the theoretical validity and the effects of homeopathic therapy, an original discipline, straddling the empirical and the experimental, a meeting point between the labelled illness and the illness as it is experienced by the patient. To do this, all the information noted about each patient and all the effects occurring after each prescription must be systematically collected and classified. This then needs to be integrated into a databank and must be made available to researchers. The aim here is to determine the position of homeopathy in medicine and analyse the benefit and limits of observational studies. The method used within the RATP medical service will then be defined. Next, the patients are classified according to their geographical origin, gender, age, their consultations over time and their role in the company. Finally, the consultations are quantified: number, sex ratio, by year, by patient and by motive and type of pathology according to the CIST 2 classification.</p></div>","PeriodicalId":39101,"journal":{"name":"Revue d''Homeopathie","volume":"12 4","pages":"Pages e49-e60"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128742729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Et si la méthode de l’évaluation d’une technologie de santé (Health Technology Assessment ou HTA) pouvait être utile à l’avenir de l’homéopathie en France ? 如果健康技术评估(HTA)的方法可能对法国顺势疗法的未来有用呢?
Q4 Medicine Pub Date : 2021-09-01 DOI: 10.1016/j.revhom.2021.07.017
Robert Kempenich (spécialiste en médecine générale)
{"title":"Et si la méthode de l’évaluation d’une technologie de santé (Health Technology Assessment ou HTA) pouvait être utile à l’avenir de l’homéopathie en France ?","authors":"Robert Kempenich (spécialiste en médecine générale)","doi":"10.1016/j.revhom.2021.07.017","DOIUrl":"10.1016/j.revhom.2021.07.017","url":null,"abstract":"","PeriodicalId":39101,"journal":{"name":"Revue d''Homeopathie","volume":"12 3","pages":"Pages 164-165"},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115373259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Qu’avez-vous retenu de votre lecture ? 你从阅读中学到了什么?
Q4 Medicine Pub Date : 2021-09-01 DOI: 10.1016/j.revhom.2021.07.015
Alain Sarembaud (Médecin homéopathe)
{"title":"Qu’avez-vous retenu de votre lecture ?","authors":"Alain Sarembaud (Médecin homéopathe)","doi":"10.1016/j.revhom.2021.07.015","DOIUrl":"https://doi.org/10.1016/j.revhom.2021.07.015","url":null,"abstract":"","PeriodicalId":39101,"journal":{"name":"Revue d''Homeopathie","volume":"12 3","pages":"Page 193"},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"137430416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Why it is necessary for homeopathic medicine to be paid for by the French National Insurance System for long term illnesses: examples from supportive care in oncology 为什么顺势疗法药物有必要由法国国民保险系统支付长期疾病的费用:从肿瘤学支持治疗的例子
Q4 Medicine Pub Date : 2021-09-01 DOI: 10.1016/j.revhom.2021.07.024
Jean-Lionel Bagot (homeopathic doctor)

Introduction

Since the 1 st January 2021, homeopathy is no longer paid for by the French National Insurance system. Without drug interference and significant side effects, popular with two-thirds of French people, homeopathy is by far the most used complementary medicine, whatever the disease. What is its real merit and what are the risks for patients with chronic conditions of having to pay for the actual cost of their medicine without any help from the French National insurance system?

Method

Review of the literature concerning the use of homeopathy in cancer care support.

Results

Homeopathy is the most widely used complementary medicine in oncology (30.7% of patients) with a very high percentage of satisfaction. The improvement in the quality of life has been shown in several studies. Better compliance with conventional cancer treatments has also made it possible to demonstrate an improvement in survival rates. Prescribed in 75% of cases by doctors, the use of homeopathy does not lead to refusal of treatment and is more and more often accepted or even recommended by oncologists. The latter are informed of these treatments in 83% of cases.

Discussion

The average prescription, respecting the recommendations of the International Homeopathic Society for Supportive Care in Oncology, is around € 50 per month. This can represent a medico-social handicap in long-term illnesses. Stopping or reducing homeopathy for economic reasons not only endangers the quality of life of these patients but also puts at risk their observance of conventional treatments with its consequent loss of opportunity.

Conclusion

We believe it is essential and urgent for the French national insurance system to return to paying for homeopathy in the framework of supportive care for long-term illnesses.

自2021年1月1日起,顺势疗法不再由法国国民保险系统支付。顺势疗法受到三分之二法国人的欢迎,没有药物干扰和明显的副作用,是迄今为止最常用的补充疗法,无论疾病是什么。它的真正优点是什么?慢性病患者在没有法国国民保险系统任何帮助的情况下必须支付实际药物费用,这有什么风险?方法回顾顺势疗法在癌症治疗支持中的应用文献。结果肌理疗法是肿瘤学中应用最广泛的补充疗法(占患者总数的30.7%),患者满意度非常高。生活质量的提高已在几项研究中得到证实。对传统癌症治疗的更好的依从性也使生存率的提高成为可能。在75%的病例中,使用顺势疗法不会导致拒绝治疗,并且越来越多地被肿瘤学家接受甚至推荐。在83%的病例中,后者被告知这些治疗方法。根据国际顺势疗法协会肿瘤支持治疗的建议,平均处方约为每月50欧元。这可能代表长期疾病的医学-社会障碍。出于经济原因而停止或减少顺势疗法不仅会危及这些患者的生活质量,而且还会危及他们遵守常规治疗的风险,从而失去机会。结论我们认为,法国国民保险制度必须在长期疾病的支持性护理框架下重新为顺势疗法支付费用。
{"title":"Why it is necessary for homeopathic medicine to be paid for by the French National Insurance System for long term illnesses: examples from supportive care in oncology","authors":"Jean-Lionel Bagot (homeopathic doctor)","doi":"10.1016/j.revhom.2021.07.024","DOIUrl":"10.1016/j.revhom.2021.07.024","url":null,"abstract":"<div><h3>Introduction</h3><p>Since the 1 <sup>st</sup><span> January 2021, homeopathy is no longer paid for by the French National Insurance system. Without drug interference and significant side effects, popular with two-thirds of French people, homeopathy is by far the most used complementary medicine, whatever the disease. What is its real merit and what are the risks for patients with chronic conditions of having to pay for the actual cost of their medicine without any help from the French National insurance system?</span></p></div><div><h3>Method</h3><p>Review of the literature concerning the use of homeopathy in cancer care support.</p></div><div><h3>Results</h3><p><span>Homeopathy is the most widely used complementary medicine in oncology (30.7% of patients) with a very high percentage of satisfaction. The improvement in the </span>quality of life<span> has been shown in several studies. Better compliance with conventional cancer treatments has also made it possible to demonstrate an improvement in survival rates. Prescribed in 75% of cases by doctors, the use of homeopathy does not lead to refusal of treatment and is more and more often accepted or even recommended by oncologists. The latter are informed of these treatments in 83% of cases.</span></p></div><div><h3>Discussion</h3><p>The average prescription, respecting the recommendations of the International Homeopathic Society for Supportive Care in Oncology, is around € 50 per month. This can represent a medico-social handicap in long-term illnesses. Stopping or reducing homeopathy for economic reasons not only endangers the quality of life of these patients but also puts at risk their observance of conventional treatments with its consequent loss of opportunity.</p></div><div><h3>Conclusion</h3><p>We believe it is essential and urgent for the French national insurance system to return to paying for homeopathy in the framework of supportive care for long-term illnesses.</p></div>","PeriodicalId":39101,"journal":{"name":"Revue d''Homeopathie","volume":"12 3","pages":"Pages e43-e47"},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129867103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bryonia/Stannum metallicum : médicament des épanchements en forme injectable. Comparaison et complémentarité des deux approches homéopathique et anthroposophique Bryonia/Stannum metallicum:可注射的扩散药物。顺势疗法和人智方法的比较和互补性
Q4 Medicine Pub Date : 2021-09-01 DOI: 10.1016/j.revhom.2021.07.023
Christian Latriche (Médecin généraliste et homéopathe et enseignant à l’IFEMA)

À partir de 2 cas cliniques, un épanchement articulaire et un épanchement pleural, deux approches médicales, homéopathique et anthroposophique, de deux médicaments communément prescrits dans ces indications : Bryonia alba et Stannum metallicum avec l’intérêt de la forme injectable.

Based on 2 clinical cases, joint effusion and pleural effusion, two medical approaches, homeopathic and anthroposophic, of two drugs commonly prescribed for these indications: Bryonia alba and Stannum metallicum with the benefit of the injectable form.

从两个临床病例,一个关节和一个胸膜灌注,两种医学方法,顺势疗法和人的方法,两种常用的药物在这些适应症:Bryonia alba和Stannum metallicum与注射形式的兴趣。根据两例临床病例,关节分泌物和胸膜分泌物,两种医学方法,顺势疗法和人的方法,常用的两种药物:Bryonia alba和Stannum metallicum,具有注射剂型的好处。
{"title":"Bryonia/Stannum metallicum : médicament des épanchements en forme injectable. Comparaison et complémentarité des deux approches homéopathique et anthroposophique","authors":"Christian Latriche (Médecin généraliste et homéopathe et enseignant à l’IFEMA)","doi":"10.1016/j.revhom.2021.07.023","DOIUrl":"10.1016/j.revhom.2021.07.023","url":null,"abstract":"<div><p>À partir de 2 cas cliniques, un épanchement articulaire et un épanchement pleural, deux approches médicales, homéopathique et anthroposophique, de deux médicaments communément prescrits dans ces indications : <em>Bryonia</em> <em>alba</em> et <em>Stannum metallicum</em> avec l’intérêt de la forme injectable.</p></div><div><p>Based on 2 clinical cases, joint effusion and pleural effusion, two medical approaches, homeopathic and anthroposophic, of two drugs commonly prescribed for these indications: <em>Bryonia alba and Stannum metallicum</em> with the benefit of the injectable form.</p></div>","PeriodicalId":39101,"journal":{"name":"Revue d''Homeopathie","volume":"12 3","pages":"Pages 156-158"},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116375268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quelle place pour le mode réactionnel chronique tuberculinique dans la pratique de l’homéopathie au XXIème siècle ? 结核菌素慢性反应模式在21世纪顺势疗法实践中的地位是什么?
Q4 Medicine Pub Date : 2021-09-01 DOI: 10.1016/j.revhom.2021.07.016
Georges Stahl (médecin homéopathe) , Jean-Lionel Bagot (médecin homéopathe)

Context

In the early 20 th century, Antoine Nebel developed a new chronic reactive mode (CRM), tuberculinism, in addition to the three “miasms” already described by Hahnemann: psora, sycosis and syphilis. How does tuberculinism fit in within the three other CRMs today?

Goal

To provide diagnostic elements so as to identify the tuberculinic CRM of a patient. To suggest the most effective therapeutic strategy.

Method

By comparing the writings of twentieth century authors with our clinical experience, we will offer the essential features and pathognomonic of tuberculinism as well as its treatment.

Results

Tuberculinism is an inherited or acquired CRM, very common in children and adolescents. It often occurs when there is a family history of tuberculosis or following BCG vaccination or repeated antibiotic therapy for recurrent ENT disorders. It evolves in two stages, acceleration of cellular metabolism then progressive exhaustion. Individuals with a phosphoric constitution are more affected. Morbid manifestations mainly evoke psora but also sycosis.

Conclusion

The recognition and management of the tuberculinic CRM make it possible to effectively treat recurrent and chronic respiratory diseases, which are very debilitating for children as well as for their parents.

在20世纪早期,Antoine Nebel发展了一种新的慢性反应模式(CRM),结核杆菌病,除了Hahnemann已经描述的三种“瘴气”:牛皮癣,梅毒和梅毒。结核病是如何在今天的其他三种crm中发挥作用的?目的为鉴别结核性CRM患者提供诊断依据。提出最有效的治疗策略。方法将20世纪作者的著作与我们的临床经验进行比较,总结结核杆菌病的基本特征、病理特征及治疗方法。结果小檗碱血症是一种遗传性或获得性CRM,常见于儿童和青少年。它通常发生在有结核病家族史或接种卡介苗或反复使用抗生素治疗复发性耳鼻喉疾病时。它的发展分为两个阶段,细胞代谢加速和逐渐衰竭。磷体质的个体受影响更大。病态表现主要引起牛皮癣,但也有精神病。结论对结核杆菌的认识和管理,可以有效地治疗复发性和慢性呼吸道疾病,这对儿童和家长来说都是非常虚弱的。
{"title":"Quelle place pour le mode réactionnel chronique tuberculinique dans la pratique de l’homéopathie au XXIème siècle ?","authors":"Georges Stahl (médecin homéopathe) ,&nbsp;Jean-Lionel Bagot (médecin homéopathe)","doi":"10.1016/j.revhom.2021.07.016","DOIUrl":"10.1016/j.revhom.2021.07.016","url":null,"abstract":"<div><h3>Context</h3><p>In the early 20 th century, Antoine Nebel developed a new chronic reactive mode (CRM), tuberculinism, in addition to the three “miasms” already described by Hahnemann: psora, sycosis and syphilis. How does tuberculinism fit in within the three other CRMs today?</p></div><div><h3>Goal</h3><p>To provide diagnostic elements so as to identify the tuberculinic CRM of a patient. To suggest the most effective therapeutic strategy.</p></div><div><h3>Method</h3><p>By comparing the writings of twentieth century authors with our clinical experience, we will offer the essential features and pathognomonic of tuberculinism as well as its treatment.</p></div><div><h3>Results</h3><p>Tuberculinism is an inherited or acquired CRM, very common in children and adolescents. It often occurs when there is a family history of tuberculosis or following BCG vaccination or repeated antibiotic therapy for recurrent ENT disorders. It evolves in two stages, acceleration of cellular metabolism then progressive exhaustion. Individuals with a phosphoric constitution are more affected. Morbid manifestations mainly evoke psora but also sycosis.</p></div><div><h3>Conclusion</h3><p>The recognition and management of the tuberculinic CRM make it possible to effectively treat recurrent and chronic respiratory diseases, which are very debilitating for children as well as for their parents.</p></div>","PeriodicalId":39101,"journal":{"name":"Revue d''Homeopathie","volume":"12 3","pages":"Pages 127-136"},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126789612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revue d''Homeopathie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1